ÂÜÀòÂÒÂ×

Bill Mullen has had a varied career in the bioscience industry. In 2008, they became the Chief Scientific Officer at Momentum Bioscience Ltd and also served as the Founder/CEO, where they developed a suite of technologies to analyse bloodstream infection. From 2006 to 2008, they were the Owner Manager at Barford Biosciences Ltd. From 2006 to 2007, they were the Chairman at ProKyma Technologies Ltd. From 2002 to 2007, they were the Founder/CEO at Acolyte Biomedica Ltd, where they developed rapid hospital microbiology products, including BacLite MRSA. Bill left the company in December 2005 and rejoined in August 2006 before selling it to 3M Healthcare in February 2007.

Bill Mullen received their Doctor of Philosophy (Ph.D.) in Biochemistry from the University of Bath in 1983, after obtaining a Bachelor's Degree from the University of Sussex in 1980.